Takeda gets shareholder approval for £46bn Shire takeover
Image copyright Reuters Takeda Pharmaceutical has secured shareholder approval for a £46bn ($59bn) takeover of UK-listed drugmaker Shire, clearing the way for Japan’s largest ever corporate acquisition. The takeover would make Takeda one of the world’s top 10 drugmakers. The deal, which needs to be approved by Shire’s shareholders, will also saddle the Japanese firm …